{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:36:44Z","timestamp":1792881404823,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.diabres.2026.113620","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:09:36Z","timestamp":1792537776000},"page":"113620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Global insulin supply insecurity and the role of manufacturing innovation"],"prefix":"10.1016","volume":"242","author":[{"given":"Irl B.","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-5355","authenticated-orcid":false,"given":"Christopher G.","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Amiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5038-6210","authenticated-orcid":false,"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Aleppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-4032","authenticated-orcid":false,"given":"David N.","family":"O\u2019Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.diabres.2026.113620_b0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(15)00521-5","article-title":"Constraints and challenges in access to insulin: a global perspective","volume":"4","author":"Beran","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.diabres.2026.113620_b0010","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-020-05375-2","article-title":"A global perspective on the issue of access to insulin","volume":"64","author":"Beran","year":"2021","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2026.113620_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001410","article-title":"Insulin prices, availability and affordability in 13 low-income and middle-income countries","volume":"4","author":"Ewen","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"9","key":"10.1016\/j.diabres.2026.113620_b0020","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.2337\/diacare.28.9.2136","article-title":"Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia","volume":"28","author":"Beran","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113620_b0025","unstructured":"American Society of Health-System Pharmacists. Drug Shortage Detail: Insulin Glargine Injection (Recombinant). Updated July 10, 2026. https:\/\/www.ashp.org\/drug-shortages\/current-shortages\/drug-shortage-detail.aspx?id=1133. Accessed July 30, 2026."},{"key":"10.1016\/j.diabres.2026.113620_b0030","unstructured":"World Health Organization. Keeping the 100-year-old promise: making insulin access universal. November 12, 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240039100. Accessed May 25, 2026."},{"issue":"5","key":"10.1016\/j.diabres.2026.113620_b0035","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2471\/BLT.18.217612","article-title":"Access to insulin: applying the concept of security of supply to medicines","volume":"97","author":"Beran","year":"2019","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.diabres.2026.113620_b0040","doi-asserted-by":"crossref","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077\u20132093. doi: 10.1016\/S0140-6736(24)02317-1.","DOI":"10.1016\/S0140-6736(24)02317-1"},{"key":"10.1016\/j.diabres.2026.113620_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112277","article-title":"Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0","volume":"225","author":"Ogle","year":"2025","journal-title":"Diabetes Res Clin Pract."},{"issue":"1","key":"10.1016\/j.diabres.2026.113620_b0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-8587(18)30303-6","article-title":"Estimation of global insulin use for type 2 diabetes, 2018\u201330: a microsimulation analysis","volume":"7","author":"Basu","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113620_b0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2026.113620_b0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/jwh.2023.0864","article-title":"Practical considerations for using continuous glucose monitoring in patients with gestational diabetes mellitus","volume":"34","author":"Castorino","year":"2025","journal-title":"J Women\u2019s Health"},{"key":"10.1016\/j.diabres.2026.113620_b0065","unstructured":"NCD Policy Lab. Documenting global insulin shortages and stockouts 2023\u20132025: comprehensive overview using various data sources. December 8, 2025. https:\/\/ncdpolicylab.org\/resources\/factsheets\/documenting-global-insulin-shortages-and-stockouts-2023-2025-comprehensive-overview-using-various-data-sources. Accessed September 28, 2026."},{"key":"10.1016\/j.diabres.2026.113620_b0070","unstructured":"World Health Organization. Global mapping of insulin manufacturers. September 9, 2026. https:\/\/www.who.int\/westernpacific\/publications\/i\/item\/B09868. See also the report summary by NCD Policy Lab: https:\/\/ncdpolicylab.org\/resources\/reports\/global-mapping-of-insulin-manufacturers. Accessed September 28, 2026."},{"issue":"10","key":"10.1016\/j.diabres.2026.113620_b0075","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/dom.12491","article-title":"Biosimilar insulins: guidance for data interpretation by clinicians and users","volume":"17","author":"Heinemann","year":"2015","journal-title":"Diabetes Obes Metab"},{"issue":"13","key":"10.1016\/j.diabres.2026.113620_b0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12934-014-0141-0","article-title":"Cell factories for insulin production","volume":"2","author":"Baeshen","year":"2014","journal-title":"Microb Cell Fact"},{"issue":"17","key":"10.1016\/j.diabres.2026.113620_b0085","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/jama.2023.20294","article-title":"Tirzepatide vs insulin lispro added to basal insulin in type 2 diabetes: the SURPASS-6 randomized clinical trial","volume":"330","author":"Rosenstock","year":"2023","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2026.113620_b0090","doi-asserted-by":"crossref","unstructured":"Cefalu WT, Dawes DE, Gavlak G, et al. Insulin Access and Affordability Working Group. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care. 2018;41(6):1299\u20131311. doi: 10.2337\/dci18-0019. Epub 2018 May 8. Erratum in: Diabetes Care. 2018;41(8):1831. doi: 10.2337\/dc18-er08.","DOI":"10.2337\/dc18-er08"},{"issue":"1","key":"10.1016\/j.diabres.2026.113620_b0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/jamainternmed.2018.5008","article-title":"Cost-related insulin underuse among patients with diabetes","volume":"179","author":"Herkert","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.diabres.2026.113620_b0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/DMSO.S126314","article-title":"Diabetes in sub-Saharan Africa - from policy to practice to progress: targeting the existing gaps for future care for diabetes","volume":"22","author":"Pastakia","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"7","key":"10.1016\/j.diabres.2026.113620_b0105","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113620_b0110","unstructured":"United Nations. Universal Declaration of Human Rights. https:\/\/www.un.org\/en\/about-us\/universal-declaration-of-human-rights. Accessed May 24, 2026."},{"issue":"5","key":"10.1016\/j.diabres.2026.113620_b0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000850","article-title":"Production costs and potential prices for biosimilars of human insulin and insulin analogues","volume":"3","author":"Gotham","year":"2018","journal-title":"BMJ Glob Health"},{"issue":"10","key":"10.1016\/j.diabres.2026.113620_b0120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12247-015-9215-8","article-title":"Modernizing pharmaceutical manufacturing: from batch to continuous production","volume":"2015","author":"Lee","year":"2015","journal-title":"J Pharm Innov"},{"key":"10.1016\/j.diabres.2026.113620_b0125","unstructured":"International Council for Harmonisation. Q13 continuous manufacturing of drug substances and drug products. Guidance for industry. U.S. Food and Drug Administration; March 2023.. Accessed May 25, 2026."},{"issue":"17","key":"10.1016\/j.diabres.2026.113620_b0130","doi-asserted-by":"crossref","first-page":"10083","DOI":"10.1021\/ie2006752","article-title":"Economic analysis of integrated continuous and batch pharmaceutical manufacturing: a case study","volume":"50","author":"Schaber","year":"2011","journal-title":"Ind Eng Chem Res"},{"key":"10.1016\/j.diabres.2026.113620_b0135","unstructured":"U.S. Food and Drug Administration. Advanced Manufacturing Technologies Designation Program: Guidance for Industry. December 2024. https:\/\/www.fda.gov\/media\/174651\/download. Accessed May 26, 2026."},{"key":"10.1016\/j.diabres.2026.113620_b0140","unstructured":"U.S. Food and Drug Administration. Executive Order 14017 on America\u2019s Supply Chains. December 19, 2024. https:\/\/www.fda.gov\/about-fda\/reports\/executive-order-14017-americas-supply-chains. Accessed May 25, 2026."},{"key":"10.1016\/j.diabres.2026.113620_b0145","unstructured":"World Health Organization. Health products policy and standards: Local production and technology transfer. https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/assistive-and-medical-technology\/medical-devices\/local-production. Accessed May 25, 2026."},{"issue":"4","key":"10.1016\/j.diabres.2026.113620_b0150","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/19322968211002514","article-title":"Inpatient insulin pen implementation, waste, and potential cost savings: a community hospital experience","volume":"15","author":"Najmi","year":"2021","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113620_b0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1057\/s41271-018-00159-w","article-title":"The importance of insulin donations for children in 43 low- and middle-income countries","volume":"40","author":"Hogerzeil","year":"2019","journal-title":"J Public Health Policy"},{"key":"10.1016\/j.diabres.2026.113620_b0160","unstructured":"International Council for Harmonisation. Stability Testing of New Drug Substances and Products Q1a(R2). February 6, 2003. https:\/\/database.ich.org\/sites\/default\/files\/Q1A%28R2%29%20Guideline.pdf. Accessed June 29, 2026."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726005401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726005401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:26:37Z","timestamp":1792880797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726005401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S0168822726005401"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113620","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global insulin supply insecurity and the role of manufacturing innovation","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113620"}}